hypogonadism as independent predictor of nodal metastases

advertisement
HYPOGONADISM IS AN INDEPENDENT PREDICTOR OF NODAL METASTASES IN
PROSTATE CANCER PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE
DISSECTION
Eugenio Ventimiglia1, Paolo Capogrosso1, Michele Colicchia1, Luca Boeri1, Alessandro
Serino1, Giulia Castagna1, Fabio Castiglione1, Giovanni La Croce1, Lorenzo Rocchini1,
Andrea Gallina1, Nazareno Suardi1, Alberto Briganti1,2, Rocco Damiano2, Montorsi
Francesco1, Andrea Salonia1,2
1Dept.
of Urology, University Vita-Salute San Raffaele, Milan, Italy
Doctorate Program in Urology, Magna Graecia University Catanzaro, Italy
2Research
OBJECTIVES - To assess the association between preoperative hypogonadism (defined
as total testosterone (tT) <3 ng/ml) with lymph node invasion (LNI) in patients treated with
radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND) for
clinically localized prostate cancer (PCa).
METHODS - Preoperative serum tT was measured in a cohort of 1009 consecutive
Caucasian-European patients (mean age 64.8 years, range 41-84) submitted to RP with
ePLND. None of the patients had taken any hormonal neoadjuvant treatment or other
hormonal preparations during the previous 12 mo. Serum tT was measured the day before
surgery (8–10 AM) in all cases. Logistic regression models tested the associations among
predictors (eg, prostate specific antigen [PSA], clinical stage, biopsy Gleason score, and
tT) and LNI.
RESULTS - Median tT was 4.5 ng/ml [mean: 4.5; range: 0.02–13.6]. Hypogonadism was
observed in 113 (11.2%) patients. LNI was found in 113 (11.2%) patients, with a mean
number of lymph nodes removed of 19.2. Mean serum tT level did not vary in patients with
LNI as compared with those without LNI; conversely, hypogonadism was found in a
significantly greater rate in pN+ patients (Chi2: 6.98; 30.1% vs 19.4%, p=0.008). UVA? At
multivariable logistic regression analysis hypogonadism emerged as an independent
predictor of LNI (OR 1.81; p=0.03), along with clinical stage (OR 2.02; p=0.04), biopsy
Gleason score (OR 14.81; p<0.001) and PSA levels (OR 1.07; p < 0.001).
CONCLUSIONS - The results of this study provide evidence that hypogonadism might
serve as an independent predictor of LNI in patients with PCa undergoing ePLND.
Download